Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer

Neal D. Freedman*, Jiyoung Ahn, Lifang Hou, Jolanta Lissowska, Witold Zatonski, Meredith Yeager, Stephen J. Chanock, Wong Ho Chow, Christian C. Abnet

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Androgens and estrogens may play a role in gastric cancer etiology. To investigate the association of gastric cancer with single-nucleotide polymorphisms (SNPs) in six genes (COMT, CYP1B1, CYP17A1, CYP19A1, HSD17B1 and SHBG) involved in estrogen and androgen synthesis and metabolism, 58 haplotype-tagging SNPs were genotyped in 295 gastric cancer cases and 415 controls from a population-based study in Poland. We assessed differences in haplotype frequency between cases and controls using a global score test and calculated multivariate odds ratios (ORs) and 95% confidence intervals (CIs) for individual haplotypes using logistic regression. We found associations in one linkage disequilibrium (LD) block containing the 3′ untranslated region of COMT (rs9332377, rs165728, rs165849 and rs1110478), global score test (df = 4, P = 0.033). Relative to the most frequent GATA haplotype, the GATG haplotype was associated with statistically significant increased gastric cancer risk (OR = 1.50, 95% CI: 1.06-2.12; false discovery rate (FDR) value = 0.459) and the AACA haplotype with borderline increased risk (OR = 1.36, 95% CI = 1.00-1.85; FDR = 0.50). We also found associations for the LD block containing part of the SHBG coding region (rs6258, rs6259, rs2955617, rs1641544 and rs1641537). The CACCC haplotype was associated with statistically significant lower gastric cancer risk relative to the referent CGACC haplotype (OR = 0.55, 95% CI = 0.34-0.90; FDR = 0.459), but the overall score test was statistically non-significant. No other statistically significant associations were observed. In summary, we found possible associations between gastric cancer and polymorphisms in COMT, involved in estrogen inactivation, and SHBG, a modulator of hormone bioavailability. These findings should be interpreted cautiously until replicated in other studies.

Original languageEnglish (US)
Pages (from-to)71-77
Number of pages7
JournalCarcinogenesis
Volume30
Issue number1
DOIs
StatePublished - 2009

Funding

USA National Cancer Institute (N02-CP-40501, N01-CP-05626, N02-CP-71103); National Cancer Institute Office of Women’s Health; In- tramural Research Program of National Institutes of Health/National Cancer Institute, Division of Cancer Epidemiology and Genetics.

ASJC Scopus subject areas

  • Cancer Research

Fingerprint

Dive into the research topics of 'Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer'. Together they form a unique fingerprint.

Cite this